KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients
暂无分享,去创建一个
Yan Shi | H. Mao | Huan Yan | Zhikuan Wang | Y. Lv | D. Sun | Zhi-yong Wu | H. Yan | Yan-rong Wang | G. Dai | Wei Shi | Yao Lv | De-cong Sun